Shionogi

Founded in 2001, Shionogi & Co., Ltd. has firmly established itself in the global pharmaceutical industry. Headquartered in the vibrant city of Osaka, Japan, Shionogi has consistently focused on pioneering research and development to address unmet medical needs. With a team of 5000 dedicated employees, the company is committed to improving patient outcomes and advancing healthcare solutions worldwide.

Under the leadership of CEO Isao Teshirogi, Shionogi continues to leverage its expertise in drug development and medical research. The company places a strong emphasis on innovation and collaboration, striving to deliver high-quality pharmaceutical products and services that enhance patient wellbeing. Shionogi's strategic partnerships and cutting-edge research initiatives reflect its dedication to tackling complex health challenges on a global scale.

With an annual revenue of £2.34 B bn, Shionogi's influence extends across various fields, including life sciences and biotechnology. The company's unwavering commitment to ethical practices and patient-centred care underpins its operations, as it relentlessly pursues solutions that improve health outcomes. As a leader in the pharmaceutical sector, Shionogi is poised to continue making significant contributions to global health and innovation.